Builder Bottle Gel Polish & Efile Course

Service Description

Builder Bottle Gel Polish & Efile Course - £165 Please note: TO USE CLEARPAY - FULL AMOUNT MUST BE SELECTED AT THE CHECKOUT This course is aimed at students who already hold a certificate in at least one aspect of nails, e.g. manicure, pedicure, gel polish, acrylic, full cover tips Join us on this full day course covering both the Builder Bottle Gel Polish also known as BIAB, and the E-filing technique. The BIAB system is much stronger than Gel Nail Polish, making it perfect for clients with thin, flexible and weak nails. It will help to promote the growth of the natural nail without the use of nail tips and harsh glue. Incorporating the E-file technique into your treatment will allow you to perform cuticle work in a speedy and gentle manner compared to traditional metal tools, we also train you how to prep the natural nail and refine the BIAB layer to achieve that super smooth finish. Finally, we cover the infill and removal procedure involved with your new nail treatment. Course content will include: Theory - Health and safety, contra-indications, contra-actions, equipment, anatomy and physiology, client consultation, aftercare advice, business building skills and troubleshooting tips Practical - Sanitising, cuticle work and nail prep using e-file attachments, application of builder bottle gel, refining nail enhancements, removal and infill procedures using e-file technique. Students are not required to bring any equipment for the training day as we provide this for you, but you will be expected to work on each other/ yourself, so please attend with grown out enhancements if possible, 2/3 weeks growth is great. If you have any concerns regarding being a model please contact us before your training date. On successful completion of this course you will receive a certificate accredited with Associated Beauty Therapists ABT, allowing you to gain industry insurance. Entry requirements: Luxury Manicure, Gel Polish or a certificate in one aspect of nails. Portfolio evidence: None